Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability

Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability

Bibliographic Details
Main Authors: Brändstedt, Jenny, Wangefjord, Sakarias, Nodin, Björn, Eberhard, Jakob, Jirström, Karin, Manjer, Jonas
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041054/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041054/

Similar Items